Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,646 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The efficacy and feasibility of dose-dense sequential chemotherapy for Japanese patients with breast cancer.
Takabatake D, Kajiwara Y, Ohtani S, Itano Y, Yamamoto M, Kubo S, Ikeda M, Takahashi M, Hara F, Aogi K, Ohsumi S, Ogasawara Y, Nishiyama Y, Hikino H, Matsuoka K, Takahashi Y, Shien T, Taira N, Doihara H. Takabatake D, et al. Among authors: ikeda m. Breast Cancer. 2018 Nov;25(6):717-722. doi: 10.1007/s12282-018-0877-1. Epub 2018 Jun 11. Breast Cancer. 2018. PMID: 29948957 Clinical Trial.
Optimizing the timing of 3.6 mg Pegfilgrastim Administration for Dose-Dense Chemotherapy in Japanese Patients with Breast Cancer.
Takabatake D, Kajiwara Y, Ohtani S, Suzuki Y, Yamamoto M, Kubo S, Ikeda M, Takahashi M, Hara F, Aogi K, Ohsumi S, Ogasawara Y, Nishiyama Y, Hikino H, Matsuoka K, Shien T, Taira N, Doihara H. Takabatake D, et al. Among authors: ikeda m. Acta Med Okayama. 2021 Jun;75(3):357-362. doi: 10.18926/AMO/62231. Acta Med Okayama. 2021. PMID: 34176940 Free article. Clinical Trial.
Long-Term Physical Activity and Body Composition After Exercise and Educational Programs for Breast Cancer: A Randomized Controlled Trial From the Setouchi Breast Project-10.
Iwamoto T, Kajiwara Y, Kawada K, Takabatake D, Miyoshi Y, Kubo S, Suzuki Y, Yamamoto M, Ogasawara Y, Hatono M, Yoshitomi S, Hara K, Sasahara A, Ohsumi S, Ikeda M, Doihara H, Mizota Y, Yamamoto S, Taira N. Iwamoto T, et al. Among authors: ikeda m. Clin Breast Cancer. 2024 Jan;24(1):27-35.e8. doi: 10.1016/j.clbc.2023.09.008. Epub 2023 Sep 17. Clin Breast Cancer. 2024. PMID: 37852895 Clinical Trial.
Systemic immunity markers are associated with clinical outcomes of atezolizumab treatment in patients with triple-negative advanced breast cancer: a retrospective multicenter observational study.
Nakamoto S, Shien T, Itoh M, Yamamoto Y, Ohsumi S, Yoshitomi S, Hikino H, Miyoshi K, Notsu A, Taira N, Doihara H, Ikeda M. Nakamoto S, et al. Among authors: ikeda m. Clin Exp Med. 2023 Dec;23(8):5129-5138. doi: 10.1007/s10238-023-01230-x. Epub 2023 Oct 30. Clin Exp Med. 2023. PMID: 37904008
Pilot trial of an electronic patient-reported outcome monitoring system in patients with metastatic breast cancer undergoing chemotherapy.
Taira N, Kikawa Y, Iwamoto T, Miyoshi Y, Hara K, Yoshitomi S, Hikino H, Takahashi H, Takabatake D, Kubo S, Ikeda M, Doihara H, Shien T, Okuyama H, Tanabe Y, Hara F, Yamanouchi K, Hagiwara Y, Sawaki M. Taira N, et al. Among authors: ikeda m. Breast Cancer. 2024 Mar;31(2):283-294. doi: 10.1007/s12282-023-01537-3. Epub 2024 Jan 4. Breast Cancer. 2024. PMID: 38175422
6,646 results